Dietz Thomas John

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 70% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -90%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Dietz Thomas John's trades of Eiger BioPharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
403.73
Quantity 86,069 +40.1%
Value US$4,819,319
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-25 2023-01-23
B Purchase
15,806 -23.4%
460.45
US$2,000,810 		15,806 -23.4% 460.45 US$2,000,810
2022-12-27 2022-12-22
S Sale
91,318 -1.9%
206.84
US$937,769 		91,318 -1.9% 206.84 US$937,769
2020-03-17 2020-03-16
B Purchase
86,069 +40.1%
403.73
US$4,819,319 		86,069 +40.1% 403.73 US$4,819,319
2020-01-13 2020-01-10
B Purchase
4,000 +20.0%
13.94
US$55,760 		4,000 +20.0% 13.94 US$55,760
2019-04-23 2019-04-23
B Purchase
5,000 +33.3%
11.10
US$55,495 		5,000 +33.3% 11.10 US$55,495
2019-04-22 2019-04-22
B Purchase
5,000 +50.0%
11.05
US$55,250 		5,000 +50.0% 11.05 US$55,250
2019-02-20 2019-02-15
PlS Planned sale
3,000 -40.0%
7.14
US$21,420 		3,000 -40.0% 7.14 US$21,420